A review of health related quality of life in systemic lupus erythematosus

Abstract

Health-related quality of life (HRQoL) is an important outcome measure in patients with systemic lupus erythematosus (SLE). A review was undertaken of the literature relating to HRQoL in SLE. MEDLINE, EMBASE, CINAHL, Allied and Complimentary Medicine were searched to locate full papers in the English language reporting on HRQoL in adult SLE patients published between 1990 and 2005. In total 53 papers were included and the review was subdivided into: 1) description of HRQoL in SLE patients; 2) HRQoL and disease activity and/or damage; 3) the impact of other variables on HRQoL; and 4) HRQoL measures used in clinical trials in SLE patients. The findings were as follows: HRQoL is reduced in SLE patients; HRQoL is not correlated to disease activity or damage; age appears to have a negative impact on HRQoL especially physical health but the effect of disease duration is unclear; other potentially modifiable variables such as fatigue and psychosocial factors impact on HRQoL in a complex manner; and HRQoL measures which are sensitive to change should be an essential outcome measure in all clinical trials on SLE patients.

Keywords

References

Maddison PJ . Is it SLE? Best Pract Res Clin Rheumatol 2002; 16: 167–180 .

Callen JP . Management of skin disease in patients with lupus erythematosus . Best Pract Res Clin Rheumatol 2002; 16: 245–264 .

Esdaile JM . How to manage patients with lupus nephritis . Best Pract Res Clin Rheumatol 2002; 16: 195–210 .

Hermosillo-Romo D , Brey RL . Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE) . Best Pract Res Clin Rheumatol 2002; 16: 229–224

Urowitz MB , Gladman D , Abu-Shakra M , Farewell V. Mortality studies in systemic lupus erythematosus:results from a single center. III. Improved survival over 24 years . J Rheumatol 1997; 24: 1061–1065 .

Bombardier C , Gladman DD , Urowitz MB , Caron D , Chang C-H , and the committee on prognosis studies in SLE . Derivation of the SLEDAI. A disease activity index for lupus patients . Arthritis Rheum 1992; 35: 630–640 .

Siegel M , Lee SL . The epidemiology of systemic lupus erythematosus . Semin Arthritis Rheum 1973; 3: 1–54 .

Gordon C , Clarke A. Quality of life and economic evaluation in SLE clinical trials . Lupus 1999; 8: 645–654 .

Seawell AH , Danoff-Burg S. Psychosocial research on systemic lupus erythematosus: a literature review . Lupus 2004; 13: 891–899 .

10.

Hochberg MC , Sutton JD . Physical disability and psychosocial dysfunction in systemic lupus erythematosus . J Rheumatol 1988; 15: 959–964 .

11.

Mitchell WD , Thompson TL . Psychiatric distress in systemic lupus erythematosus outpatients . Psychosomatics 1990; 31: 293–300 .

12.

Omdal R , Husby G , Mellgren SI . Mental health status in systemic lupus erythematosus . Scand J Rheumatology 1995; 24: 142–145 .

13.

Waterloo K , Omdal R , Husby G , Mellgren SI . Emotional status in systemic lupus erythematosus . Scand. J Rheumatology 1998; 27: 410–414 .

14.

Gladman D , Urowitz MB , Ong A , Gough J , MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus . Lupus 1996; 5: 190–195 .

15.

Devins GM , Edworthy SM . Illness intrusiveness explains race-related quality of life differences among women with systemic lupus erythematosus . Lupus 2000; 9: 534–541 .

16.

Hanly JG . Disease activity, cumulative damage and quality of life in systemic lupus erythematosus: results of a cross-sectional study . Lupus 1997; 6: 243–247 .

17.

Gladman DD , Urowitz MB , Ong A , Gough OJ , MacKinnon A. Lack of correlation among 3 outcomes describing SLE:disease activity, damage and quality of life . Clin Exp Rheumatol 1996; 14: 305–308 .

18.

Sutcliffe N , Stoll T , Pyke S , Isenberg D. Functional disability and end organ damage in patients with SLE, SLE and Sjogren's syndrome and primary SS . J Rheumatol 1998; 25: 63–68 .

19.

Stoll T , Stucki G , Malik J , Pyke S , Isenberg DA . Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus . Ann Rheum Dis 1996; 55: 756–760 .

20.

Stoll T , Gordon C , Burckhardt CS et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; it's association with disease activity and damage in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 1608–1614 .

21.

Thumboo J , Fong KY , Ng TP , Leong KH , Feng PH , Boey ML . Initial construct cross-cultural validation of the short form 36 for quality of life assessment of systemic lupus erythematosus patients in Singapore . Ann Acad Med Singapore 1997; 26: 282–284 .

22.

Gilboe IM , Kvien TK , Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls . J Rheumatol 1999; 26: 1694–1700 .

23.

Rinaldi S , Doria A , Salaffi F et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age . Rheumatol 2004; 43: 1574–1579 .

24.

Sutcliffe N , Clarke A , Levington C , Frost C , Gordon C , Isenberg D. Associates of health status in patients with systemic lupus erythematosus . J Rheumatol 1999; 26: 2352–2356 .

25.

Vu TV , Escalante A. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease . J Rheumatol 1999; 26: 2595–2601 .

26.

Wang C , Mayo NE , Fortin PR . The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus . J Rheumatol 2001; 28: 525–532 .

27.

Friedman AW , Alarcon GS , McGwin G Jr , Straaton KV , Reveille JD . Systemic lupus erythematosus in three ethnic groups. IV:Factors associated wtih self-reported functional outcome in a large cohort study . Arthritis Care Res 1999; 12: 256–266 .

28.

Lash AA . Quality of life in systemic lupus erythematosus . Appl Nurs Res 1998; 11: 130–137 .

29.

Burckhardt CS , Archenholtz B , Bjelle A. Quality of life of women with systemic lupus erythematosus:a comparison with women with rheumatoid arthritis . J Rheumatol 1993; 20: 977–981 .

30.

Abu-Shakra M , Mader R , Langevitz P et al. Quality of life in systemic lupus erythematosus:A controlled study . J Rheumatol 1999; 26: 306–309 .

31.

Jolly M , Utset TO . Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus 2004; 13: 924–926 .

32.

Boomsma MM , Bijl M , Stegeman CA , Kallenberg CGM , Hoffman GS , Tervaert JWC . Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income and interpersonal relationships: a comparison with Wegener's granulomatosis . Arthritis Care Res 2002; 47: 196–201 .

33.

DaCosta D , Dobkin PL , Fitzcharles MA et al. Determinants of health status in fibromyalgia:A comparative study with systemic lupus erythematosus . J Rheumatol 2000; 27: 365–372 .

34.

Gladman DD , Urowitz MB , Gough J , MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus . J Rheumatol 1997; 24: 2145–2148 .

35.

Khanna S , Pal H , Pandey RM , Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus . Rheumatol 2004; 43: 1536–1540 .

36.

Thumboo J , Fong KY , Ng T-P et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore . J Rheumatol 1999; 26: 97–102 .

37.

Thumboo J , Feng PH , Soh CH , Boey ML , Thio ST , Fong KY . Validation of a Chinese version of the medical outcomes study family and marital functioning measures in patients with SLE . Lupus 2000; 9: 702–707 .

38.

Dobkin PL , DaCosta D , Dritsa M et al. Quality of life in systemic lupus erythematosus patients during more or less active disease states: differential contributors to mental and physical health . Arthritis Care Res 1999; 12: 401–410 .

39.

Saba J , Quinet RJ , Davis WE et al. Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM) . Joint Bone Spine 2003; 70: 348–351 .

40.

Doria A , Rinaldi S , Ermani M et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants . Rheumatol 2004; 43: 1580–1586 .

41.

Thumboo J , Fong KY , Chan SP et al. A prospective study of factors affecting quality of life in systemic lupus erythematosus . J Rheumatol 2000; 27: 1414–1420 .

42.

Alarcon GS , McGwin G Jr , Uribe A et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of selfreported health related quality of life early in disease course . Arthritis Care Res 2004; 51: 465–474 .

43.

Fortin PR , Abramamowicz M , Neville C et al. Impact of disease activity and cumulative damage on the health of lupus patients . Lupus 1998; 7: 101–107 .

44.

Gilboe IM , Kvien TK , Husby G. Disease course in systemic lupus erythematosus:changes in health status, disease activity and organ damage after 2 years . J Rheumatol 2001; 28: 266–274 .

45.

Dobkin PL , DaCosta D , Fortin PR et al. Living with lupus: a prospective pan-canadian study . J Rheumatol 2001; 28: 2442–2448 .

46.

McHorney CA , Ware JE , Raczek AE . The MOS 36-item short form health survey (SF-36). II Psychometric and clinical tests of validity in measuring physical and mental health contructs . Med Care 1993; 31: 247–263 .

47.

Ragsdale D , Morrow JR . Quality of life as a function of HIV classification . Nurs Res 1990; 39: 355–359 .

48.

Bombardier C , Gladman DD , Urowitz MB , Caron D , Chang C-H , and the committee on prognosis studies in SLE . Derivation of the SLEDAI . A disease activity index for lupus patients . Arthritis Rheum 1992; 35: 630–640 .

49.

Liang MH , Socher SA , Larson MG , Schur PH . Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus . Arthritis Rheum 1989; 32: 1107–1118 .

50.

Hay EM , Bacon PA , Gordon C et al. The BILAG index:a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus . Q J Med 1993; 86: 447–458 .

51.

Vitali C , Bencivelli W , Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research II: Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE . Clin Exp Rheumatol 1992; 10: 541–547 .

52.

Gladman DD , Urowitz MB , Goldsmith CH et al. The reliability of the systemic lupus international collaborating clinics/American college of rheumatology damage index in patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 809–813 .

53.

Bruce IN , Mak VC , Hallett DC , Gladman DD , Urowitz MB . Factors associated with fatigue in patients with systemic lupus erythematosus . Ann Rheum Dis 1999; 58: 379–381 .

54.

Wang B , Gladman DD , Urowitz MB . Fatigue in lupus is not correlated with disease activity . J Rheumatol 1998; 25: 892–895 .

55.

Lwin CTT , Bishay M , Platts RG , Booth DA , Bowman SJ . The assessment of fatigue in primary Sjogren's syndrome . Scand J Rheumatol 2003; 32: 33–37 .

56.

Zonana-Nacach A , Roseman JM , McGwin G Jr et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA study group. LUpus in MInority populations. NAture vs Nurture . Lupus 2000; 9: 101–109 .

57.

Tayer WG , Nicassio PM , Weisman MH , Schuman C , Daly J. Disease status predicts fatigue in systemic lupus erythematosus . J Rheumatol 2001; 28: 1999–2007 .

58.

Krupp LB , LaRocca NG , Muir J , Steinberg AD . A study of fatigue in systemic lupus erythematosus . J Rheumatol 1990; 17: 1450–1452 .

59.

Wysenbeek AJ , Leibovici L , Weinberger A , Guedj D. Fatigue in systemic lupus erythematosus, prevalence and relation to disease expression . Br J Rheumatol 1993; 32: 633–635 .

60.

Taylor J , Skan J , Erb N et al. Lupus patients with fatigue–is there a link with fibromyalgia syndrome? Rheumatol 2000; 39: 620–623 .

61.

Godaert GLR , Hartkamp A , Geenen R et al. Fatigue in daily life in patients with primary Sjoegren's syndrome and systemic lupus erythematosus. Neuroendocrine immune basis of the rheumatic diseases II : In Cutolo M , Bijlsma JWJ eds. Proceedings of the second international conference. Annals of the New York Academy of Sciences 2002; 966: 320–326 .

62.

McKinley PS , Ouellette SC , Winkel GH . The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus . Arthritis Rheum 1995; 38: 826–834 .

63.

Omdal R , Waterloo K , Koldingsnes W , Husby G , Mellgren SI . Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects . J Rheumatol 2003; 30: 283–287 .

64.

Karasz A , Ouellette SC . Role strain and psychological well-being in women with systemic lupus erythemtosus . Women Health 1995; 23: 41–56 .

65.

Wekking EM , Vingerhoets AJJM , van Dam AP , Nossent JC , Swaak AJJG . Daily stressors and systemic lupus erythematosus:A longitudinal analysis–first findings . Psychotherapy Psyscomatic 1991; 55: 108–113 .

66.

Dobkin PL , Fortin PR , Joseph L , Esdaile JM , Danoff DS , Clarke A. Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus . Arthritis Care Res 1998; 11: 23–31 .

67.

Corzillius M , Bae SC . Methodological issues of corticosteroids use in SLE clinical trials . Lupus 1999; 8: 692–697 .

68.

Strand V , Gladman D , Isenberg D , Petri M , Smolen J , Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus . J Rheumatol 1999; 26: 490–497 .

69.

Strand V. Clinical trials design in systemic lupus erythematosus: lessons learned and future directions . Lupus 2004; 13: 406–411 .

70.

Tugwell P , Chambers L , Torrance G et al. The population health impact of arthritis . J Rheumatol 1993; 20: 1048–1051 .

71.

Furie RA , Cash JM , Cronin ME et al. Treatment of systemic lupus erythematosus with LJP 394 . J Rheumatol 2001; 28: 257–265 .

72.

Polderman MC , Huizinga TW , Le-Cessie S , Pavel S . UVA-1 cold light treatment of SLE: a double blind placebo controlled crossover trial . Ann Rheum Dis 2001; 60: 112–115 .

73.

Dobkin PL , DaCosta D , Joseph L et al. Counterbalancing patient demands with evidence:results from a pan-canadian randomised clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus . Ann Behav Med 2002; 24: 88–99 .

74.

Strand V , Aranow C , Cardiel M et al. Improvement of health-related quality of life in SLE patients enrolled in a randomised clinical trial comparing LJP 394 treatment with placebo . Lupus 2003; 12: 677–686 .

75.

Karlson EW , Liang MH , Eaton H et al. A randomised clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus . Arthritis Rheum 2004; 50: 132–1841 .

76.

Nordmark G , Bengtsson C , Larsson A , Karlsson FA , Sturfelt G , Ronnblom L. Effects of dehydroepiandrosterone supplement on healthrelated quality of life in glucocorticoid treated female patients with systemic lupus erythematosus . Autoimmunity 2005; 38: 531–540 .

77.

Schinffenbauer J , Simon LS . Randomised controlled trials in systemic lupus erythematosus:what has been done and what do we need to do? Lupus 2004; 13: 398–405 .

78.

Gudbjornsson B , Hetta J. Sleep disturbances in patients with systemic lupus erythematosus:a questionnaire-based study . Clin Exp Rheumatol 2001; 19: 509–514 .

79.

DaCosta D , Bernatsky S , Dritxa M et al. Determinants of sleep quality in women with systemic lupus erythematosus . Arthritis Care Res 2005; 53: 272–278 .

80.

Curry SL , Levine SB , Corty E , Jones PK , Kurit DM . The impact of systemic lupus erythematosus on women's sexual functioning . J Rheumatol 1994; 21: 2254–2260 .

81.

Berzon R , Hays RD , Shumaker SA . International use, application and performance of health-related quality of life instruments . Qual Life Res 1993; 2: 367–368 .

82.

Leong KP , Kong KO , Thong BYH et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL) . Rheumatol 2005; 44: 1267–1276 .

83.

McElhone K , Shelmerdine J , Bruce IN et al. Development and validation of a disease-specific health-related quality of life (HRQoL) measure, the LupusQoL, for adults with systemic lupus erythematosus (SLE) . Arthritis Care Res (in press).